Contraceptives Market Size

  • Report ID: 4635
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Contraceptives Market Outlook:

Contraceptives Market size was valued at USD 21.97 billion in 2025 and is set to exceed USD 38.61 billion by 2035, expanding at over 5.8% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of contraceptives is estimated at USD 23.12 billion.

The rising need for effective family planning and government initiatives and support to raise awareness about birth control is estimated to have a positive impact on market growth. In 2020, the U.S. government invested about USD 600 million to enhance family planning and provide reproductive health services across the world.

In addition to the aforementioned factors, the rising focus on preventing unintended pregnancy is anticipated to boost the market growth of the global contraceptives market. As per the estimations, about half of all pregnancies occurring in the world are unwanted i.e., nearly 120 million pregnancies every year are unintended. Moreover, increased awareness about health issues associated with teenage pregnancies and high abortion rates among the population are other factors that are projected to create a positive outlook for market expansion. Also, the increase in participation of reproductive women in the labor force, the implementation of programs at reducing unwanted pregnancies, and the high number of women with unmet contraceptive drugs and devices are other factors that are expected to boost the expansion of the market size. Furthermore, the growing prevalence of sexually transmitted diseases (STDs) is also anticipated to increase the sales of contraceptives in the upcoming years.


Contraceptives Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of contraceptives is estimated at USD 23.12 billion.

The global contraceptives market size crossed USD 21.97 billion in 2025 and is likely to expand at a CAGR of around 5.8%, surpassing USD 38.61 billion revenue by 2035.

North America contraceptives market will secure around 39.8% share by 2035, driven by growing contraceptive awareness and STD prevention efforts.

Key players in the market include Novartis Pharmaceutical Corporation, Agile Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Piramal Group, Viatris Inc., Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos